Novo Nordisk advances obesity candidate to late-stage program after weight loss of less than 12% US$ 23.78 Min. order: 1 piece ★★★★★ 4.0 (161 reviews) Sold : Login>>
Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly US$ 21.95 Min. order: 1 piece ★★★★★ 4.8 (201 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 23.48 Min. order: 1 piece ★★★★★ 4.5 (71 reviews) Sold : Login>>
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial US$ 22.58 Min. order: 1 piece ★★★★★ 4.0 (171 reviews) Sold : Login>>
Novo Nordisk Offers New Contender in Weight Management US$ 26.12 Min. order: 1 piece ★★★★★ 4.0 (239 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.98 Min. order: 1 piece ★★★★★ 4.4 (41 reviews) Sold : Login>>